Common heart pill tested as secret weapon against ovarian cancer
Disease control
Completed
This small, early-stage study tested whether adding a common cholesterol-lowering drug (simvastatin) to standard chemotherapy could help slow the progression of recurrent ovarian cancer. It involved 18 women whose cancer had returned but was still sensitive to platinum-based drug…
Phase: EARLY_PHASE1 • Sponsor: Marc Goodman • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC